Rosen's Breast Pathology, 4e

930

Chapter 33

7. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 1991;67:869–872. 8. Ahn BY, Kim HH, Moon WK, et al. Pregnancy-and lactation-­ associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 2003;22:491–497. 9. Mazonakis M, Varveris H, Damilakis J, et al. Radiation dose to con­ ceptus resulting from tangential breast irradiation. Int J Radiat Oncol Biol Phys 2003;55:386–391. 10. Swinford AE, Adler DD, Garver KE. Mammographic appearance of the breasts during pregnancy and lactation: false assumptions. Acad Radiol 1998;5:467–472. 11. Liberman L, Geiss CS, Dershaw DD, et al. Imaging of pregnancy-­ associated breast cancer. Radiology 1994;191:245–248. 12. Hogge JP, Shaw de Paredes E, Magnant DM, et al. Imaging and man­ agement of breast masses during pregnancy and lactation. Breast J 1999;5:272–283. 13. Sabate JM, Clotet M, Torrubia S, et al. Radiologic evaluation of breast disorders related to pregnancy and lactation. Radiographics 2007;27:S101–S124. 14. Yang WT, Dryden MJ, Gwyn K, et al. Imaging of breast cancer di­ agnosed and treated with chemotherapy during pregnancy. Radiology 2006;239:52–60. 15. Espinosa LA, Daniel BL, Vidarsson L, et al. The lactating breast: ­contrast-enhanced MR images of normal tissue and cancer. Radiology 2005;237:429–436. 16. Loibl S, von Minckwitz G, Gwyn K, et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 2006;106:237–246. 17. Bottles K, Taylor RN. Diagnosis of breast masses in pregnant and lactat­ ing women by aspiration cytology. Obstet Gynecol 1985;66:76S–78S. 18. Novotny DB, Maygarden SJ, Shermer RW, et al. Fine needle aspiration of benign and malignant breast masses associated with pregnancy. Acta Cytol 1991;35:676–686. 19. Ishida T, Yokoe T, Kasumi F, et al. Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 1992;83:1143–1149. 20. Tobon H, Horowitz LF. Breast cancer during pregnancy. Breast Dis 1993;6:127–134. 21. King RM, Welch JS, Martin Jr JK, et al. Carcinoma of the breast associ­ ated with pregnancy. Surg Gynecol Obstet 1985;160:228–232. 22. Ribeiro G, Jones DA, Jones M. Carcinoma of the breast associated with pregnancy. Br J Surg 1980;73:607–609. 23. Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer 2003;98:1055–1060. 24. Reed W, Sandstad B, Holm R, et al. The prognostic impact of hor­ mone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and the cell cycle. Int J Surg Pathol 2003;11:65–74. 25. Elledge RM, Ciocca DR, Langone G, et al. Estrogen receptor, proges­ terone receptor, and HER-2/neu protein in breast cancers from preg­ nant patients. Cancer 1993;71:2499–2506. 26. Shousha S. Breast carcinoma presenting during or shortly after preg­ nancy and lactation. Arch Pathol Lab Med 2000;124:1053–1060. 27. García-Manero M, Royo MP, Espinos J, et al. Pregnancy associated breast cancer. Eur J Surg Oncol 2009;35:215–218. 28. Abellar RG, Pepperell JR, Greco D, et al. Effects of chemotherapy ­during pregnancy on the placenta. Pediatr Dev Pathol 2009;12:35–41. 29. Pavlidis N, Pentheroudakis G. The pregnant mother with breast cancer: diagnostic and therapeutic management. Cancer Treat Rev 2005;31:439–447. 30. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report on 84 children who received chemotherapy in utero. Clin Lym- phoma 2001;2:173–177. 31. Gemignani ML, Petrek JA. Pregnancy-associated breast cancer: diag­ nosis and treatment. Breast J 2000;6:68–73. 32. Colfry AJ III. Miscellaneous syndromes and their management: ­occult breast cancer, breast cancer in pregnancy, male breast cancer, surgery in stage IV disease. Surg Clin North Am 2013;93:519–531. 33. Daniilidis A, Giannoulis C, Sardeli C, et al. Pregnancy-associated breast cancer—a review analysis. Eur J Gynaecol Oncol 2010;31:485–490.

34. Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat 2008;108:333–338. 35. Kuerer HM, CunninghamJD, Bleiweiss IJ, et al. Conservative surgery for breast carcinoma associated with pregnancy. Breast J 1999;4:171–176. 36. Gentilini O, Gremonesi M, Trifiro G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 2004;15:1348–1351. 37. Keleher A, Wendt R III, Delpassand E, et al. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99 m sulfur col­ loid. Breast J 2004;10:492–495. 38. Mondi MM, Cuenca RE, Ollila DW, et al. Sentinel lymph node bi­ opsy during pregnancy: initial clinical experience. Ann Surg Oncol 2007;14:218–221. 39. Khera SY, Kiluk JV, Hasson DM, et al. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J 2008;14:25–254. 40. Pruthi S, Haakenson C, Brost BC, et al. Pharmacokinetics of methy­ lene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy. Am J Surg 2011;201:70–75. 41. Spanheimer PM, Graham MM, Sugg SL, et al. Measurement of uter­ ine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol 2009;16:1143–1147. 42. Anderson BO, Petre JA, Byrd DR, et al. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age or younger. Am J Obstet Gynecol 1996;3:204–211. 43. Nugent P, O’Connell TX. Breast cancer in pregnancy. Arch Surg 1985;120:1221–1224. 44. Maggard MA, O’Connell JB, Lane KE, et al. Do young breast cancer patients have worse outcomes? J Surg Res 2003;113:109–113. 45. Guinee VF, Olsson H, Möller T, et al. Effect of pregnancy on prognosis for young women with breast cancer. Lancet 1994;343:1587–1589. 46. Surbone A, Petrek JA. Childbearing issues in breast carcinoma survi­ vors. Cancer 1997;79:1271–1278. 47. Danforth DN. How subsequent pregnancy affects outcome in women with a prior breast cancer. Oncology 1991;11:23–29. 48. Petrek JA. Pregnancy safety after breast cancer. Cancer 1994;74:528–531. 49. Lawrenz B, Banys M, Henes M, et al. Pregnancy after breast cancer: case report and review of the literature. Arch Gynecol Obstet 2011; 283:837–843. 50. Velentgas P, Daling JR, Malone KE, et al. Pregnancy after breast carci­ noma:outcomesandinfluenceonmortality. Cancer 1999;85:2424–2432. 51. Salamon MA, Sherer DM, Saller DNJ, et al. Placental metastases in a patient with recurrent breast carcinoma. Am J Obstet Gynecol 1994;171:573–574. 52. Eltorky M, Khare VK, Osborne P, et al. Placental metastasis from maternal carcinoma. A report of three cases. J Reprod Med 1995;40:399–403. 53. Tan K, Sinclair E, Angus G, et al. Mucinous adenocarcinoma of the breast metastatic to the placenta. Pathology 2010;42:688–690. Carcinoma in Young Adult Women 54. Chung M, Chang HR, Bland KI, et al. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77:97–103. 55. Simmons PS, Jayasinghe YL, Wold LE, et al. Breast carcinoma in young women. Obstet Gynecol 2011;118:529–536. 56. Kothari AS, Beechey-Newman N, D’Arrigo C, et al. Breast carcinoma in women age 25 years or less. Cancer 2002;94:606–614. 57. Feldman AL, Welch JP. Long-term outcome in women less than 30 years of age with breast cancer. J Surg Oncol 1998;68:193–198. 58. Xiong Q, Valero V, Kau V, et al. Female patients with breast carci­ noma age 30 years and younger have a poor prognosis. The M.D. ­Anderson Cancer Center experience. Cancer 2001;92:2523–2528. 59. Peng R, Wang S, Shi Y, et al. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a ret­ rospective matched case-control study. Breast 2011;20:568–573. 60. Liukkonen S, Leidenius M, Saarto T, et al. Breast cancer in very young women. Eur J Surg Oncol 2011;37:1030–1037. 61. Lein BC, Alex WR, Zebley M, et al. Results of needle localized breast biopsy in women under age 50. Am J Surg 1996;171:356–359.